Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Bus Load of Faith
View:
Post by Camphikefish on Sep 07, 2022 10:31am

Bus Load of Faith

Seriously folks, this is one tough stock to wrap my head around. Is it truly possible to go back to .15 cents and rise from the ashes again ? Yes I trust the science but it seems like almost a pipe dream to think we will reach my $10 personal target from here. How do we have a compound which beats the stand alone competition without large chunks being purchased? Not selling but wondering if I am missing something all these years? Is the tech not adoptable? Is it held down because it's a threat? Does the market really want a cure or is the revenue stream of lifelong treatments from other modalities the secret enemy of a one two Tld punch? Talk me back to my happy place .
Comment by Rumpl3StiltSkin on Sep 07, 2022 10:56am
These prices are manipulated. This represents the best value for TLT I've seen since being invested in it. Considering how de-risked it is. It is a no-brainer buying at these prices and if someone wanted a large position SP would quickly ramp.
Comment by Mikee3003 on Sep 07, 2022 12:08pm
Agreed, if a buyer were to now take a large position the price most certainly would jump quickly. However until this period of uncertainty remains nobody will buy this stock at an aggresive pace. Why would they? Wait for the pp get the stock at today's price or better including a warrant or percent of. Frustrating that management is nowhere to be seen.  Ask yourself this....why are ...more  
Comment by Pandora on Sep 07, 2022 10:59am
You are mostly in the fold of big Pharma and their associated regulators -- that's a very high hurdle to jump.
Comment by Yoly900 on Sep 07, 2022 11:09am
Banktruptcy at its finest coming soon soon enough 0.15 than once she breaks 0.14 it's all over to 0.00 it's been tough years of this shite finally coming to a closure and they're suing me fk you 
Comment by ScienceFirst on Sep 07, 2022 12:54pm
Few years ago, we didn't have the data.  We were also trailblazers, hoping.  And the issue regarding the first 12 patients was a reminder that you have to have statistically significant data to step in in volume when it comes to big players.  Breakthrough designation should attract big players, no doubt.  The pace of enrollment should, overtime, benefit of such ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250